{"editorial":{"content_id":"4a5f956e-e2c9-4c3f-9d5b-21ef073ebf29","slug":"anvisa-dcb-20261013-235483","content_type":"news","title":"巴西Anvisa更新通用名称清单，新增24个DCB","summary":"巴西国家卫生监督局通过第473/2026号规范性指令发布更新版巴西通用名称（DCB）清单，新增24个名称。","body":"巴西国家卫生监督局（Anvisa）宣布，通过发布第473/2026号规范性指令（IN 473/2026），正式更新巴西通用名称（Denominações Comuns Brasileiras，DCB）清单，本次更新新增24个DCB。\n\n更新后的DCB综合清单已在Anvisa数字图书馆发布，可通过 http://bibliotecadigital.anvisa.gov.br/jspui/handle/anvisa/22551 查阅。更多信息可参见SEI流程25351.900083/2025-46。\n\n据Anvisa说明，巴西通用名称（DCB）是经负责卫生监督的联邦机构批准的药物或活性成分名称，依据1999年第9.787号法律。随着电子注册的推行，该术语的概念已有所扩展，目前还包括非活性原料、超免疫血清和疫苗、放射性药物、药用植物、顺势疗法物质和生物制品的名称。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["政策","合规","行业趋势","br-health"],"content_level":"编辑整理","event_type":"政策法规","audience_tags":[],"event_location":null,"verification_status":"source_verified","published_at":"2026-10-13T17:00:56.040Z","display_date":"2026-10-13","source_published_at":null,"source_url":"https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-publica-lista-atualizada-das-denominacoes-comuns-brasileiras-2","source_name":"Anvisa","source_language":"pt","author_name":"编辑部","risk_level":"low","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/anvisa-dcb-20261013-235483","api_url":"https://chinabrazilinsight.com/api/public/content/anvisa-dcb-20261013-235483","markdown_url":"https://chinabrazilinsight.com/api/public/content/anvisa-dcb-20261013-235483?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/anvisa-dcb-20261013-235483?view=json","last_updated":"2026-10-13T17:01:20.604Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}